Edition:
United States

Harvard Bioscience Inc (HBIO.OQ)

HBIO.OQ on NASDAQ Stock Exchange Global Market

2.30USD
25 May 2017
Change (% chg)

-- (--)
Prev Close
$2.30
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
12,201
52-wk High
$3.88
52-wk Low
$2.25

HBIO.OQ

Chart for HBIO.OQ

About

Harvard Bioscience, Inc. is a developer, manufacturer and marketer of a range of scientific instruments, systems and lab consumables used for basic research, drug discovery, clinical and environmental testing. The Company's products are sold to thousands of researchers in over 100 countries through its global sales organization,... (more)

Overall

Beta: 1.18
Market Cap(Mil.): $79.62
Shares Outstanding(Mil.): 34.62
Dividend: --
Yield (%): --

Financials

  HBIO.OQ Industry Sector
P/E (TTM): -- 44.47 17.43
EPS (TTM): -0.14 -- --
ROI: -4.85 8.90 -5.41
ROE: -6.28 13.88 -4.69

BRIEF-Harvard Bioscience reports Q1 non-GAAP earnings $0.02/shr

* Harvard Bioscience reports first quarter 2017 financial results

Apr 27 2017

BRIEF-Harvard Bioscience Inc files for non-timely 10-K

* Harvard Bioscience Inc files for non-timely 10-K - sec filing Source text (http://bit.ly/2nwkqVz) Further company coverage:

Mar 17 2017

BRIEF-Harvard Bioscience Q4 gaap loss per share $0.04

* Harvard Bioscience reports fourth quarter and year-end 2016 results and 2017 financial guidance

Mar 09 2017

BRIEF-Metabolix announces name change to Yield10 Bioscience Inc

* Effective at market open on Monday, January 9, 2017, trading for Yield10 Bioscience will begin under symbol "YTEN" Source text for Eikon: Further company coverage:

Jan 06 2017

More From Around the Web

Earnings vs. Estimates